Share on StockTwits

Cytomedix (NASDAQ:CMXI) Insider Dean Tozer bought 40,000 shares of the stock in a transaction that occurred on Friday, August 29th. The stock was purchased at an average cost of $0.35 per share, with a total value of $14,000.00. Following the completion of the transaction, the insider now directly owns 126,700 shares of the company’s stock, valued at approximately $44,345. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link.

Shares of Cytomedix (NASDAQ:CMXI) traded up 1.07% on Thursday, hitting $0.379. 127,095 shares of the company’s stock traded hands. Cytomedix has a 52 week low of $0.33 and a 52 week high of $0.68. The stock has a 50-day moving average of $0.39 and a 200-day moving average of $0.46. The company’s market cap is $47.2 million.

Cytomedix, Inc is a United States-based company that develops biologically active regenerative therapies for wound and tissue repair.

Receive News & Ratings for Cytomedix Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cytomedix Inc and related companies with Analyst Ratings Network's FREE daily email newsletter.